Basim Anwar Shehata Messiha

Basim Anwar Shehata Messiha

Auto-generated profile, based on publicly available information

Basim Anwar Shehata Messiha

Department of Pharmacology and Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2017 in Clinical and Experimental Pharmacology and Physiology
Verified
Journal Article
Closed access
HHHesham Fathy Hassan Hassan
Hesham Fathy Hassan Hassan
AMAhmed Mohamed Mansour
Ahmed Mohamed Mansour
AAAmira Morad Hussein Abo‐Youssef
Amira Morad Hussein Abo‐Youssef
BEBakheet Elsadek
Bakheet Elsadek
BMBasim Anwar Shehata Messiha
Basim Anwar Shehata Messiha

24 December 2015 in Pharmaceutical Biology
Verified
Journal Article
Closed access
PDF file
MWMariam G. F. Wahba
Mariam G. F. Wahba
BMBasim A. S. Messiha
Basim A. S. Messiha
AAAli A. Abo-Saif
Ali A. Abo-Saif
Context Fibrates were reported to have anti-inflammatory effects while the naturally occurring polyphenol resveratrol was traditionally known as a potent antioxidant agent. Objective The effects of fenofibrate and resveratrol were investigated on complete Freund’s adjuvant (CFA)-induced rheumatoid arthritis (RA) in adult female albino rats. Materials and methods Rats were divided into a normal control group, an arthritis control group receiving CFA, two reference treatment groups receiving dexamesathone (1.5 mg/kg/day) and methotrexate (1 mg/kg/day), and two treatment groups receiving fenofibrate (100 mg/kg/day) and resveratrol (10 mg/kg/day) for seven consecutive days. Assessment of RA was performed by measuring serum rheumatoid factor (RF), matrix metalloprotinease-3 (MMP-3) and cartilage oligomeric matrix protein (COMP) as specific rheumatoid biomarkers, immunoglobulin G (IgG) and antinuclear antibody (ANA) as immunological biomarkers, tumour necrosis factor-alpha (TNF-α) and interleukin-10 (IL-10) as immunomodulatory cytokines, myeloperoxidase (MPO) and C-reactive protein (CRP) as inflammatory biomarkers and malondialdehyde (MDA) and glutathione (GSH) as oxidative stress biomarkers, supported by a histopathological study on joints and spleens. Results Serum RF, MMP-3, COMP, IgG, ANA, TNF-α, MPO, CRP and MDA were decreased to about 36, 56, 66, 65, 9, 35, 24, 44 and 31% by fenofibrate, and to about 37, 59, 44, 70, 5, 30, 23, 33 and 28% by resveratrol treatments, respectively. Alternatively, serum IL-10 and GSH were significantly increased to about 215 and 251% by fenofibrate and to about 225 and 273% by resveratrol treatments, respectively. Discussion and conclusion Fenofibrate and resveratrol protect against RA, possibly through their immunomodulatory, anti-inflammatory and antioxidant potential.

30 March 2016 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Closed access
PDF file
MAMohammed Ragab Abdel-Aziz Ali
Mohammed Ragab Abdel-Aziz Ali
AAAmira Morad Hussein Abo-Youssef
Amira Morad Hussein Abo-Youssef
BMBasim Anwar Shehata Messiha
Basim Anwar Shehata Messiha
MKMahmoud Mohamed Khattab
Mahmoud Mohamed Khattab

25 October 2019 in Antioxidants
Verified
Journal Article
Open access
PDF file
SZSameh S. Zaghlool
Sameh S. Zaghlool
AAAli A. Abo-Seif
Ali A. Abo-Seif
MRMohamed A. Rabeh
Mohamed A. Rabeh
Usama AbdelmohsenUsama Abdelmohsen
Usama Abdelmohsen
BMBasim A. S. Messiha
Basim A. S. Messiha
Recently, an alternative disease treatment approach is the research of medicaments from traditional medicine. Plants with anti-oxidant capabilities are used as herbal treatments for ulcer diseases. Medicinal/herbal extracts containing phytoconstituents have significant anti-ulcer activities in in vivo experiments on animal models, compared to reference drugs. The current study aims to inspect gastro-protective as well as in vitro and in vivo anti-oxidant potential of Althaea officinalis and Solanum nigrum extracts on pyloric-ligation/indomethacin-induced gastric-ulceration in rats. Rats were divided into six groups: normal control, gastric ulcer control, two standard pretreatment groups receiving omeprazole and misoprostol, and two test pretreatment groups receiving Althaea officinalis and Solanum nigrum. Pretreatments were administrated orally for 14 days. On the 15th day, animals, excluding the normal control group, were exposed to pyloric-ligation followed by indomethacin injection. After four hours, the rat’s stomachs were removed and gastric juice and blood samples were collected. Pyloric-ligation/indomethacin administration caused considerable elevation in ulcer number, ulcer index, acid and pepsin productivity, aggressive factors, and gastric mucosal lipid-peroxide contents. Moreover, reduction in titratable acidity, gastric mucosal nitric-oxide, anti-oxidant contents, and protective factors accompanied gastric-ulceration. Additionally, elevation in pro-inflammatory cytokines content and reduction in cystathionine-β-synthase and heme-oxygenase-1 expression was witnessed. Omeprazole, misoprostol, Althaea officinalis, and Solanum nigrum pretreatments fixed blood and tissue biomarkers, thereby protecting them from pyloric-ligation/indomethacin-induced gastric-ulceration in rats, which is hopeful for clinical examinations.

1 October 2015 in European Journal of Pharmacology
Verified
Journal Article
Closed access
MWMariam Gamal Fahmy Wahba
Mariam Gamal Fahmy Wahba
BMBasim Anwar Shehata Messiha
Basim Anwar Shehata Messiha
AAAli Ahmed Abo-Saif
Ali Ahmed Abo-Saif

1 August 2018 in Drug and Chemical Toxicology
Verified
Journal Article
Closed access
MEMohamed G. Ewees
Mohamed G. Ewees
BMBasim A. S. Messiha
Basim A. S. Messiha
MAMohamed Sadek Abdel-Bakky
Mohamed Sadek Abdel-Bakky
ABAsmaa M.A. Bayoumi
Asmaa M.A. Bayoumi
AAAli A. Abo-Saif
Ali A. Abo-Saif
Cisplatin (CP) is one of the most potent anti-cancer drugs used against different types of cancer. Its use is limited due to its nephrotoxicity. This study is aimed to evaluate the role of a super oxide dismutase (SOD) mimetic agent, tempol, in protection against CP nephrotoxicity in rats. Animals were divided into four groups: Group-1: Normal control group, Group-2: CP group (single dose of CP 6 mg/kg, i.p.), Group-3 and Group-4: Tempol-treated groups (50 mg/kg p.o. and 100 mg/kg p.o. respectively) daily for a week before CP injection and continued for an additional four days after CP injection. Urine and blood samples were collected for the evaluation of kidney function including serum creatinine, BUN, cystatin-c, and creatinine clearance. In addition, western blotting was used to determine urine lipocalin-2 content. Furthermore, kidney tissue was collected for the determination of oxidative stress markers, caspase-3 expression, and histopathological examination. We noticed that both doses of tempol significantly improved kidney function, which was deteriorated by CP injection. Tempol significantly elevated kidney glutathione (GSH) content and SOD activity, and decreased kidney lipid peroxidation and NOx production. Tempol also significantly decreased kidney caspase-3 expression which was elevated by CP toxicity. Thus, we conclude that tempol can protect against CP nephrotoxicity. We noticed that both doses of tempol are effective in ameliorating CP-nephrotoxicity.